Efficacy and safety of selpercatinib in Chinese patients with advanced RET fusion-positive non-small-cell lung cancer: a phase II clinical trial (LIBRETTO-321)
暂无分享,去创建一个
Ying Cheng | Shun Lu | Jianying Zhou | Chengzhi Zhou | Dingzhi Huang | Ye Guo | Lin Wu | S. Lu | Wanli Zhang | Yuping Sun | Jingxin Shao